Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer
Abstract Background Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited. Methods An aqueous extract from pine-mistletoe was used to investigate maximum tolerable dose (MTD) and safety of intravenous appli...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2017-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|